Skip to main content

Table 2 Behavioral measures for Study 2 comparing participants from lorazepam, placebo, and yohimbine groups

From: An elevated plus-maze in mixed reality for studying human anxiety-related behavior

Measures

Lorazepam

Placebo

Yohimbine

Mean

± SE

Min

Max

Mean

± SE

Min

Max

Mean

± SE

Min

Max

Latency open arm exploration (s)

42.1

9.5

5.3

113.8

92.9

25.8

9.8

300

148.9

34.4

4.2

300

Latency open arm end exploration (s)

133.6

26.6

15.5

300

177.1

28.7

17.6

300

193.4

31.7

11.5

300

Time on open arms (s)

131.3

9.6

52.8

187.4

97.8

15.5

0

195.0

58.1

14.6

0

146.7

Time on open arms (%)

43.8

3.2

17.6

62.5

32.6

5.2

0

65.0

19.4

4.9

0

48.9

Time on closed arms (s)

46.1

5.6

10.8

105.3

39.1

9.5

0

165.3

53.3

15.4

0

218.2

Time in center (s)

122.1

9.7

77.0

207.8

162.4

18.4

79.4

300

187.9

19.5

81.1

300

Time in center and on closed arms (s)

168.2

9.5

111.9

246.4

201.6

15.6

104.2

300

241.2

15.6

152.6

300

Time in immobility (s)

198.2

8.4

131.6

269.5

205.7

15.7

86.0

300

219.4

13.2

114.6

290.8

Average velocity on open arms (m/s)

0.044

0.004

0.019

0.083

0.040

0.007

0

0.099

0.032

0.007

0

0.081

Average velocity on closed arms (m/s)

0.074

0.006

0.032

0.129

0.070

0.012

0

0.148

0.061

0.011

0

0.139

Total distance covered (m)

13.6

1.0

6.5

25.1

12.6

1.8

0

27.9

11.1

1.4

3.8

22.9

Number of entries open arms (n)

4.4

0.6

0

11

4.3

0.8

0

10

2.9

0.7

0

9

Number of entries closed arms (n)

2.9

0.3

1

6

2.4

0.4

0

5

2.1

0.4

0

5

  1. Measures are given as mean ± SE
  2. SE standard error, Min minimum, Max maximum values